Comments Regarding Proposed Rule for Nonprescription Drug Product With an Additional Condition for Nonprescription Use Share page: Docket Number: FDA–2021–N–0862 Download Document Issues: OTC Medicines Rx-to-OTC Switch Related Posts Comments Comments Regarding Reauthorization of the Over-the-Counter Monograph Drug User Fee Program Oct 27, 2023 Timeline for an FDA Order to Determine a Drug is Not GRAS/E Oct 20, 2023 Press Releases and Statements CHPA SVP of Regulatory & Scientific Affairs Delivers Remarks at FDA OMUFA Public Meeting Sep 28, 2023